0
Applied AI·November 20, 2026·1 min read

Novartis CEO: AI Could Cut Drug Development Time by Years

Share

A top pharma CEO saying AI could cut development from 12 to 8 years and improve success odds is a signal that big budgets will follow — and that regulators will be pushed to adapt. If you build tools for discovery, trials, or real-world evidence, this is your window to align with pharma workflows before standards harden.